InflaRx NV (IFRX)
2.08
+0.02
(+0.97%)
USD |
NASDAQ |
Nov 22, 16:00
2.10
+0.02
(+0.96%)
After-Hours: 20:00
InflaRx Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2023
--
Maximum
Sep 2023
--
Average
--
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| Affimed NV | 0.469 |
| BioNTech SE | 0.0127 |
| Immatics NV | 0.00 |
| CureVac NV | 0.00 |
| ATAI Life Sciences NV | 0.1561 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 89.00M |
| Total Liabilities (Quarterly) | 16.09M |
| Shareholders Equity (Quarterly) | 72.91M |
| Current Ratio | 5.308 |